Chemical genetic control of cytokine signaling in CAR-T cells using lenalidomide-controlled membrane-bound degradable IL-7
Michael C. Kann(Massachusetts General Hospital), Max Jan(Broad Institute)
Cited by 6
Related Papers
Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomide
|Science Translational Medicine|2021|257
Targeting solid tumor antigens with chimeric receptors: cancer biology meets synthetic immunology
|Trends in cancer|2024|27